Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. About KenvueKenvue is the world’s largest pure-play consumer health company by revenue.
Kenvue drives climate action strategy forward
The Store is equipped with interactive displays to showcase our brands on their best day and serves as a visual reminder of our 135+ years of experience, providing care in the moments that matter most. In addition to product sales, Kenvue invests in marketing initiatives, which enhance brand visibility and awareness. The company’s annual marketing expenditure has reached around $1 billion, with a significant focus on digital advertising and influencer partnerships. This investment has yielded a substantial return, with brand loyalty metrics improving by 12% year-over-year. Through strategic brand management and marketing initiatives, Kenvue aims to improve brand loyalty. Current estimates suggest that Kenvue has a brand loyalty rate of approximately 75% among its key products, which is a crucial driver for repeat sales.
new product innovations each year since 2020
As part of its initial public offering (IPO), Kenvue raised approximately $3.8 billion, significantly bolstering its financial standing. The initial stock price was set at $22 per share, and as of the latest trading session, it has fluctuated around $26 to $30, marking a healthy debut in the market. The name had to complement the in-market product brand names by living on packaging and standing for a compelling and unifying idea. Our work impacts consumers and colleagues, communities and generations, in daily rituals and in the moments that matter most. This incredible responsibility means every decision and action we take is guided by integrity and quality. At Kenvue we put people first, and our new home is being built with that at its core.
Kenvue Inc., a prominent player in the consumer health sector, operates with a clear emphasis on its mission to promote health and well-being. The company’s mission statement focuses on empowering people to live their best lives through innovative personal care and health products. According to Kenvue’s latest SEC filings, the company aims to provide solutions that enhance everyday health, which underscores its commitment to consumer welfare and product effectiveness.
We earn trust with science
The company aims to leverage its established brands in the consumer health space, which includes products like Tylenol, Listerine, and Neutrogena. And our work is to put that power into the hands of consumers around the world,” Mongon adds. As Kenvue continues to leverage its strong brand portfolio and focus on consumer health trends, the company’s financial performance is likely to remain robust, driven by innovation, strategic marketing, and expanding e-commerce presence.
And, even more fitting, “K” comes after “J” in the English alphabet, a subtle nod to Kenvue as the name of the consumer health sector’s next chapter. Then, with an eye towards global growth, we created the brand’s Chinese name, which successfully achieved phonetic similarity with the English name. Formerly the Consumer Healthcare division of Johnson & Johnson,3 Kenvue is the proprietor of well-known brands such as Aveeno,4 Band-Aid,5 Benadryl, Combantrin, Zyrtec,6 Johnson’s,7 Listerine,8 Mylanta, Neutrogena,4 Trosyd, Calpol, Tylenol,8 and Visine. We know each individual has a personal preference on how — and where — they like to work. That’s why we designed a space that enables Kenvuers to work from anywhere, including outside, with ergonomic furniture, Wi-Fi and power throughout. “Neighborhoods,” or various sections of the building, are allocated based on workflows.
In May 2023, Kenvue made our debut as a public company on the New York Stock Exchange, trading under the KVUE ticker symbol. Today, Kenvue is the world’s largest pure-play consumer health company by revenue, with annual sales of ~$15 billion in 2022. As of the end of 2023, Kenvue’s product portfolio includes well-known brands such as Tylenol, Band-Aid, and Neutrogena, each aligning with their mission to provide reliable and accessible health and personal care products.
- As of the latest filings, the largest shareholders of Kenvue Inc. include both institutional and individual investors.
- As of September 2023, Kenvue continued to see positive momentum in its stock performance, with shares trading around $25.30, marking a year-to-date increase of over 15%.
- The breakdown of ownership categories is significant as institutional investors typically hold a major portion of the equity.
Kenvue was officially announced in September 2022, poising this world leader in consumer health how do i invest in oil direct and indirect options for exciting growth as it forges ahead in its planned next chapter as a standalone company. We are committed to continuously improving our sustainability efforts through our brands, packaging and operations, delivering on the expectations of today’s consumers. Our Healthy Lives Mission strives to advance the well-being of both your health and the planet’s health. We’re working to improve the sustainability of our products, packaging and operations to build lasting positive change for people, communities and the one planet we call home. We’ve always prioritized science as the core of how we provide care, and this will never change. We believe everyday care can not only make people well, it can make them whole.
Deep Dive: Research and Development 2025
We’re driven to win for those we serve, and when we care fiercely for them and one another, we can deliver the best possible care. Our committed collaboration fuels our relentless external competitive drive — because the stronger our bonds are, the stronger our brands are, too. Summit’s high quality of life, including excellent schools, parks and amenities, will further enhance the well-being and satisfaction of our Kenvue team members and promotes our people-first approach. The city’s vibrant downtown adds even more value, with access to top-tier dining, shopping and more.
consumer health
This site is governed solely by applicable U.S. laws and governmental regulations. Use of this site constitutes your consent to application of such laws and regulations. Your use of the information on this site is subject to our Terms of Service in the Legal Notice. You should view the Media section in order to receive the most current information made available by Kenvue. Built on more than a century of heritage and propelled forward by science, our portfolio of iconic brands redefines what care really means.
That’s why our iconic brands have helped generations take care of themselves and their loved ones for more than 135 years. For example, the creation of BAND-AID® Brand HYDRO SEAL™ acne blemish patches was born out of viral social media skincare trends. The development of this product demonstrates how Kenvue boldly pursues innovative ways to work, creating solutions that can genuinely improve people’s lives. From gently cleaning tiny fingers during a baby’s first bath to coinspot review protecting the vitality of your skin to soothing aches and pains — our products deliver safe, effective, everyday care at every stage of life. Our diverse, agile and energized team is united by an unwavering courage to see and solve everyday care needs with science-backed, care-forward experiences.
- Our work impacts consumers and colleagues, communities and generations, in daily rituals and in the moments that matter most.
- Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.
- The overall financial health of Kenvue is also evidenced by its operating income, which stood at approximately $3.3 billion for the fiscal year 2022, translating to an operating margin of 25%.
- By the end of its first trading day on May 19, 2023, Kenvue’s stock rose to $24.21, reflecting an increase of 10% from its IPO price, giving the company a market capitalization of approximately $41 billion.
- An Insights Lab, a high tech, multi-room experience, is designed to transform how Kenvue develops, tests, and showcases its products.
- The company’s annual marketing expenditure has reached around $1 billion, with a significant focus on digital advertising and influencer partnerships.
With empathy, we unearth extraordinary breakthroughs in everyday care, and with courage and conviction, we bring them to life. We boldly pursue more innovative ways of working, pioneer solutions that improve lives, and create products that create categories — then improve them again and again. Generating clinical studies and real-world evidence helps to develop and improve our products and brands. Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise. Kenvue’s mission statement serves not only as a guiding principle but also as a strategic framework that shapes its operational initiatives and marketing strategies. This alignment of corporate goals with a commitment to consumer welfare is instrumental in driving growth, pips and points meeting consumer demand, and enhancing shareholder value.
Among institutional investors, notable holders include Vanguard Group, which holds approximately 8% of the total shares, and BlackRock, with around 7%. Other significant institutional investors comprise Fidelity Investments, State Street Corporation, and T. Their collective influence plays a vital role in the governance and strategic decisions of the company.
Our Healthy Lives Mission — our environmental, social and governance strategy — strives to nurture healthy people, enrich a healthy planet and maintain healthy practice. Within our three Healthy Lives Mission pillars, we are focused on nine priority topics and have set goals and commitments to hold us accountable and help drive the positive impact we aim to create. Kenvue, which manufactures brands such as Tylenol, Neutrogena and Listerine, is investing in advanced artificial intelligence capabilities that will include work with generative AI, digital twins, smart agents, predictive analytics and machine-enabled collaboration. Kenvue is due to become active in 2023, subject to legal requirements that include the necessary consultations with works councils and employee representatives. There are an estimated one billion consumers of the trusted brands that will fall under the new company name.
As of the latest filings, the largest shareholders of Kenvue Inc. include both institutional and individual investors. The breakdown of ownership categories is significant as institutional investors typically hold a major portion of the equity. Select to analyze similar companies using key performance metrics; select up to 4 stocks. Kenvue investigates and leverages the latest science and emerging technologies to supercharge your care and well-being.